Role of protease-activated receptor-1 in brain injury after experimental global cerebral ischemia

Stroke

Volumn 43, Issue 9, 2012, Pages 2476-2482

  Wang, Jinhu ^a   Jin, Hang ^a   Hua, Ya ^a   Keep, Richard F ^a   Xi, Guohua ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

brain edema; global cerebral ischemia; mitogen activated protein kinases; protease activated receptor 1 (PAR 1); thrombin

Indexed keywords

GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 1; SYNAPTOPHYSIN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAUDATE NUCLEUS; CELL DEATH; COMMON CAROTID ARTERY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HISTOLOGY; MALE; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WATER; BODY WEIGHT; BRAIN; BRAIN ISCHEMIA; CELL COUNT; CELL DEATH; CEREBROVASCULAR CIRCULATION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE STRENGTH; POSTURAL BALANCE; RECEPTOR, PAR-1; THROMBIN;

EID: 84865606155     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.661819     Document Type: Article

References (33)

1. Khot S, Tirschwell DL. Long-term neurological complications after hypoxic-ischemic encephalopathy. Semin Neurol. 2006;26:422-431.
2. Xi G, Reiser G, Keep RF. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem. 2003;84:3-9.
3. Karabiyikoglu M, Hua Y, Keep RF, Ennis SR, Xi G. Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow. J Cereb Blood Flow Metab. 2004;24: 159-166.
4. Hu H, Yamashita S, Hua Y, Keep RF, Liu W, Xi G. Thrombin-induced neuronal protection: role of the mitogen activated protein kinase/ribosomal protein s6 kinase pathway. Brain Res. 2010;1361:93-101.
5. Chen B, Cheng Q, Yang K, Lyden PD. Thrombin mediates severe neurovascular injury during ischemia. Stroke. 2010;41:2348-2352.
6. Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, et al. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci. 2001;14:595-608.
7. Wang H, Ubl JJ, Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia. 2002;37:53-63.
8. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
9. Hamill CE, Mannaioni G, Lyuboslavsky P, Sastre AA, Traynelis SF. Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function. Exp Neurol. 2009;217:136-146.
10. Henrich-Noack P, Riek-Burchardt M, Baldauf K, Reiser G, Reymann KG. Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra. Brain Res. 2006;1070:232-241.
11. Olson EE, Lyuboslavsky P, Traynelis SF, McKeon RJ. PAR-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia/ischemia. J Cereb Blood Flow Metab. 2004;24: 964-971.
12. Junge CE, Sugawara T, Mannaioni G, Alagarsamy S, Conn PJ, Brat DJ, et al. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci U S A. 2003;100:13019-13024.
13. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1982;11: 491-498.
14. Olsson T, Wieloch T, Smith ML. Brain damage in a mouse model of global cerebral ischemia. Effect of NMDA receptor blockade. Brain Res. 2003;982:260-269.
15. Yoshioka H, Niizuma K, Katsu M, Okami N, Sakata H, Kim GS, et al. NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. J Cereb Blood Flow Metab. 2011;31:868-880.
16. Yoshioka H, Niizuma K, Katsu M, Sakata H, Okami N, Chan PH. Consistent injury to medium spiny neurons and white matter in the mouse striatum after prolonged transient global cerebral ischemia. J Neu-rotrauma. 2011;28:649-660.
17. Shavit E, Michaelson DM, Chapman J. Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglial crosstalk on peri-synaptic astrocytic endfeet. J Neurochem. 2011;119:460-473.
18. Xi G, Keep RF, Hua Y, Xiang J, Hoff JT. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke. 1999; 30:1247-1255.
19. Gu Y, Hua Y, Keep RF, Morgenstern LB, Xi G. Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke. 2009;40:2241-2243.
20. Rodriguez R, Santiago-Mejia J, Gomez C, San-Juan ER. A simplified procedure for the quantitative measurement of neurological deficits after forebrain ischemia in mice. J Neurosci Meth. 2005;147:22-28.
21. Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG, Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci U S A. 2000;97: 2264-2269.
22. Hua Y, Keep RF, Hoff JT, Xi G. Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab. 2003;23:1448-1454.
23. Xi G, Hua Y, Wu J, Keep RF. Increase of brain thrombin concentration in cerebral ischemia. Stroke. 2002;33:399.
24. Weinstein JR, Lau AL, Brass LF, Cunningham DD. Injury-related factors and conditions down-regulate the thrombin receptor (PAR-1) in a human neuronal cell line. J Neurochem. 1998;71:1034-1050.
25. Mima T, Jin YJ, Hirayama T, Mostafa MG, Mori K. Argatroban, a thrombin inhibitor, decreased mortality after 10 min of forebrain ischemia in the gerbil. Neurosci Lett. 2000;279:93-96.
26. Ohyama H, Hosomi N, Takahashi T, Mizushige K, Kohno M. Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia. Brain Res. 2001;902:264-271.
27. Irving EA, Bamford M. Role of mitogen-and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab. 2002;22:631-647.
28. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68:320-344.
29. Nito C, Kamada H, Endo H, Niizuma K, Myer DJ, Chan PH. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab. 2008;28: 1686-1696.
30. Sawe N, Steinberg G, Zhao H. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res. 2008;86:1659-1669.
31. Narasimhan P, Liu J, Song YS, Massengale JL, Chan PH. VEGF stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothe-lial cells after ischemic conditions. Stroke. 2009;40:1467-1473.
32. Xi G, Hua Y, Keep RF, Duong HK, Hoff JT. Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance. Brain Res. 2001;895:153-159.
33. Ohnishi M, Katsuki H, Fujimoto S, Takagi M, Kume T, Akaike A. Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury. Exp Neurol. 2007;206:43-52.